Company Releases Results of Tourette Drug Study (Premium)
On October 5, 2023, Emalex Biosciences released safety data on the use of its investigational drug, ecopipam, for pediatric patients with Tourette syndrome after 12 months of use. Tourette syndrome is a chronic, childhood-onset neurodevelopmental […]